应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ADTX ADiTx Therapeutics
已收盘 11-25 16:00:00 EST
0.4000
+0.0611
+18.03%
盘后
0.3900
-0.0100
-2.50%
19:58 EST
最高
0.4227
最低
0.3351
成交量
546.37万
今开
0.3380
昨收
0.3389
日振幅
25.85%
总市值
569.37万
流通市值
569.37万
总股本
1,423万
成交额
211.44万
换手率
38.38%
流通股本
1,423万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
ADiTx Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aditxt, Inc.于2017年9月28日根据特拉华州法律注册成立。该公司是一家临床前阶段的生命科学公司,致力于延长移植患者的生命和提高移植患者的生活质量。他们拥有独家全球许可证,用于将这种基于核酸的技术称为Apoptotic DNA Immunotherapy(ADi),该技术利用新的方法模仿他们的身体自然诱导对自身组织的耐受性。该公司计划开发用于器官移植,植皮和创伤愈合的ADi产品,最初的重点是皮肤移植和其他器官和组织同种异体移植。
发行价格:
--
{"stockData":{"symbol":"ADTX","market":"US","secType":"STK","nameCN":"ADiTx Therapeutics","latestPrice":0.4,"timestamp":1732568400000,"preClose":0.3389,"halted":0,"volume":5463699,"hourTrading":{"tag":"盘后","latestPrice":0.39,"preClose":0.4,"latestTime":"19:58 EST","volume":78048,"amount":30811.7016,"timestamp":1732582695768},"delay":0,"floatShares":14234210,"shares":14234210,"eps":-1591.3079,"marketStatus":"已收盘","marketStatusCode":5,"change":0.0611,"latestTime":"11-25 16:00:00 EST","open":0.338,"high":0.4227,"low":0.3351,"amount":2114407.5302230497,"amplitude":0.258483,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1591.3079,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732611600000},"adr":0,"listingDate":1593489600000,"adjPreClose":0.3389,"preHourTrading":{"tag":"盘前","latestPrice":0.3356,"preClose":0.3389,"latestTime":"09:29 EST","volume":5661,"amount":1909.3381173,"timestamp":1732544993752},"postHourTrading":{"tag":"盘后","latestPrice":0.39,"preClose":0.4,"latestTime":"19:58 EST","volume":78048,"amount":30811.7016,"timestamp":1732582695768},"volumeRatio":4.86217,"impliedVol":6.3423,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ADTX/tweets","defaultTab":"tweets","newsList":[],"profile":{"websiteUrl":"http://www.aditxt.com","stockEarnings":[{"period":"1week","weight":0.0492},{"period":"1month","weight":-0.6316},{"period":"3month","weight":-0.9906},{"period":"6month","weight":-0.9958},{"period":"1year","weight":-0.9975},{"period":"ytd","weight":-0.9987}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aditxt, Inc.于2017年9月28日根据特拉华州法律注册成立。该公司是一家临床前阶段的生命科学公司,致力于延长移植患者的生命和提高移植患者的生活质量。他们拥有独家全球许可证,用于将这种基于核酸的技术称为Apoptotic DNA Immunotherapy(ADi),该技术利用新的方法模仿他们的身体自然诱导对自身组织的耐受性。该公司计划开发用于器官移植,植皮和创伤愈合的ADi产品,最初的重点是皮肤移植和其他器官和组织同种异体移植。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.093384},{"month":2,"riseRate":0,"avgChangeRate":-0.153549},{"month":3,"riseRate":0.25,"avgChangeRate":-0.034533},{"month":4,"riseRate":0.25,"avgChangeRate":-0.206094},{"month":5,"riseRate":0.25,"avgChangeRate":-0.074716},{"month":6,"riseRate":0,"avgChangeRate":-0.280139},{"month":7,"riseRate":0.2,"avgChangeRate":-0.115338},{"month":8,"riseRate":0.2,"avgChangeRate":0.340652},{"month":9,"riseRate":0,"avgChangeRate":-0.532},{"month":10,"riseRate":0,"avgChangeRate":-0.317503},{"month":11,"riseRate":0.2,"avgChangeRate":-0.2711},{"month":12,"riseRate":0.5,"avgChangeRate":-0.051784}],"exchange":"NASDAQ","name":"ADiTx Therapeutics","nameEN":"ADiTx Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ADiTx Therapeutics(ADTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ADiTx Therapeutics(ADTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ADiTx Therapeutics,ADTX,ADiTx Therapeutics股票,ADiTx Therapeutics股票老虎,ADiTx Therapeutics股票老虎国际,ADiTx Therapeutics行情,ADiTx Therapeutics股票行情,ADiTx Therapeutics股价,ADiTx Therapeutics股市,ADiTx Therapeutics股票价格,ADiTx Therapeutics股票交易,ADiTx Therapeutics股票购买,ADiTx Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADiTx Therapeutics(ADTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ADiTx Therapeutics(ADTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}